SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-051169
Filing Date
2024-02-29
Accepted
2024-02-28 19:40:44
Documents
5
Effectiveness Date
2024-02-29

Document Format Files

Seq Description Document Type Size
1 S-8 d734742ds8.htm S-8 49749
2 EX-5.1 d734742dex51.htm EX-5.1 8313
3 EX-23.2 d734742dex232.htm EX-23.2 1719
4 EX-FILING FEES d734742dexfilingfees.htm EX-FILING FEES 20350
5 GRAPHIC g734742g0228004936911.jpg GRAPHIC 2408
  Complete submission text file 0001193125-24-051169.txt   84640
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277494 | Film No.: 24698155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)